Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Peginterferon Alfa-2a (Pegasys) and Adeforvir Dipivoxil (ADV) in Participants With Lamivudine-Resistant Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B [Phase 4]
A Phase 4 study evaluating the efficacy and safety of peginterferon alfa-2a (Pegasys) and adefovir dipivoxil (ADV) in lamivudine-resistant, …
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infection [NA]
The document summarizes completion of a non-investigational study evaluating adenovirus serotype 5 neutralizing antibodies in patients with …
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients [Phase 3]
Phase 3 trial evaluating Niuliva® to prevent hepatitis B virus recurrence in liver transplant recipients. The study is completed with result…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B. [Phase 4]
Phase 4 study of PEGASYS (peginterferon alfa-2a) in HBeAg-positive chronic hepatitis B has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: A Study of Early Immunologic Response in Asian Patients With Chronic Hepatitis B, Treated With Pegasys (Peginterferon Alfa-2a (40KD)), Nucleoside Analogues, or Both [Phase 1]
Phase 1 trial in Asian patients with chronic hepatitis B evaluating early immunologic response to Pegasys or nucleoside analogues (or both);…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: Bioequivalence Study to Compare the Pharmacokinetics of Besifovir in Healthy Adult Volunteers [Phase 1]
Phase 1 bioequivalence study in healthy adults assessing the pharmacokinetics of Besifovir has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet [Phase 1]
Phase 1 study comparing the safety and pharmacokinetics of CKD-390 tablets with Viread tablets in chronic hepatitis B; the trial has complet…
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination [Phase 3]
Phase 3 trial update reports antibody persistence at ages 3.5 and 4.5 years after primary and booster vaccination with DTaP-IPV-HepB-PRP~T o…
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected Patients [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating the safety and efficacy of REP 2139 (REP 9AC') in patients with chronic hepatitis B infection.
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Therapeutic Safety and Efficacy of REP 9AC (REP 2055) in HBV or HCV Infected Patients [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating the safety and efficacy of REP 9AC (REP 2055) in patients with chronic hepatitis B or hepatitis C…
-
CLINICAL_TRIALS trial_result · 2016-01-01Clinical Trial Update: Addition of PegIFN Alfa-2a to CHB Patients Treated With Nucleot(s)Ides [Phase 4]
Phase 4 clinical trial update on adding pegylated interferon alfa-2a to chronic hepatitis B patients already treated with nucleos(t)ide anal…
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: An Observational Study of Peginterferon Alfa-2a (PEGASYS®) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B
This clinical trial update reports results from an observational study of peginterferon alfa-2a (PEGASYS) in patients with chronic hepatitis…
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load [NA]
A clinical trial update reports on lamivudine therapy in chronic hepatitis B patients previously treated with entecavir and with undetectabl…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B [Phase 4]
Phase 4 clinical trial evaluating PEGASYS (peginterferon alfa-2a) in combination with adefovir or entecavir for HBeAg-positive chronic hepat…
-
CLINICAL_TRIALS trial_result · 2015-11-11Clinical Trial Update: Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions
This clinical trial update assesses the hepatic safety of currently used antiretroviral regimens in patients with chronic hepatitis and HIV …
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis B
A prospective study evaluating noninvasive methods to evaluate liver fibrosis in patients with chronic hepatitis B has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen [Phase 2]
A Phase 2 dose-ranging study of pegylated interferon lambda in HBeAg-positive hepatitis B patients has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-07Clinical Trial Update: Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED) [Phase 3]
Phase 3 trial of an investigational V441-001 vaccine in healthy infants in Taiwan has completed, targeting diphtheria, tetanus, pertussis, h…
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Validity of Elastography During Pregnancy
A clinical trial evaluating the validity of elastography during pregnancy has been suspended, affecting pregnant women with hepatitis B.
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients [Phase 4]
Phase 4 trial evaluating blood glucose during infusion with HepaGam B in hepatitis B patients after liver transplant. Results have been post…
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at Birth [Phase 3]
Phase 3 trial of the DTaP-IPV-HepB-PRP-T pentavalent vaccine in Indian infants completed; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection [Phase 4]
A Phase 4 trial evaluating induction of fibrosis regression in patients with chronic hepatitis B and liver fibrosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-09-14Clinical Trial Update: Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma [NA]
This document reports a completed clinical trial evaluating whether specific modulation frequencies differentiate Hepatitis B carriers with …
-
CLINICAL_TRIALS trial_result · 2015-09-09Clinical Trial Update: Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B [Phase 4]
This Phase 4 trial evaluated whether combining Tenofovir disoproxil fumarate with peginterferon alfa-2a improves efficacy and safety versus …
-
CLINICAL_TRIALS trial_result · 2015-09-03Clinical Trial Update: Activation of Hepatitis B Virus (HBV) in Hepatitis B Surface Antigen (HBsAg) - Negative But Hepatitis B Core Antibody (Anti-HBc) - Positive Patients
This completed clinical trial investigates activation of hepatitis B virus in patients who are HBsAg-negative but Anti-HBc-positive, indicat…